primary peritoneal carcinoma

Showing 76 - 100 of 105

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Peritoneal Carcinomatosis From Ovarian Cancer, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma Trial in El Palmar.

Unknown status
  • Peritoneal Carcinomatosis From Ovarian Cancer
  • +2 more
  • Cytoreduction
  • Hipec with Cisplatin
  • El Palmar., Murcia, Spain
    Hospital Clínico Universitario Virgen de la Arrixaca
Dec 12, 2017

Ovarian Cancer, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma Trial in Minneapolis (Fludarabine, Cyclophosphamide, NK

Completed
  • Ovarian Cancer
  • +2 more
  • Minneapolis, Minnesota
    University of Minnesota Masonic Cancer Center
Dec 3, 2017

Malignant Ovarian Mixed Epithelial Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma Trial in

Terminated
  • Malignant Ovarian Mixed Epithelial Tumor
  • +7 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Aug 8, 2017

Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma Trial in Philadelphia (drug, procedure,

Withdrawn
  • Fallopian Tube Carcinoma
  • +4 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 12, 2017

Primary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma Trial in Philadelphia (Paclitaxel Poliglumex)

Completed
  • Primary Peritoneal Carcinoma
  • Recurrent Ovarian Carcinoma
  • Paclitaxel Poliglumex
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 12, 2017

Primary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma Trial in Phoenix (Cositecan, Pharmacological Study)

Completed
  • Primary Peritoneal Carcinoma
  • Recurrent Ovarian Carcinoma
  • Phoenix, Arizona
    Gynecologic Oncology Group of Arizona
Jul 12, 2017

Advanced Ovarian Carcinoma, Primary Peritoneal Carcinoma, Ovarian Carcinosarcoma Trial in Oklahoma City (Avastin, Paclitaxel,

Completed
  • Advanced Ovarian Carcinoma
  • +2 more
  • Oklahoma City, Oklahoma
    University of Oklahoma Health Sciences Center
Jun 2, 2017

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Boston (Tivozanib)

Terminated
  • Ovarian Cancer
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
May 4, 2017

Breast Cancer, Cervical Cancer, Endometrial Cancer Trial in Los Angeles, New York (compound 31543 Calcitriol)

Completed
  • Breast Cancer
  • +7 more
  • compound 31543 Calcitriol
  • Los Angeles, California
  • +1 more
Apr 21, 2017

Ovarian Carcinoma, Stage 3 or 4, Epithelial Ovarian Carcinoma, Primary Peritoneal Carcinoma Trial in Portland (Paclitaxel,

Withdrawn
  • Ovarian Carcinoma, Stage 3 or 4
  • +2 more
  • Portland, Oregon
    Oregon Health & Science University
Apr 19, 2017

Invasive Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer Trial in St Louis (Propranolol)

Completed
  • Invasive Epithelial Ovarian Cancer
  • +2 more
  • St Louis, Missouri
    Washington University in St. Louis
Jan 11, 2017

Bulky Stage IIIC and IV Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in China (PEip

Completed
  • Bulky Stage IIIC and IV Epithelial Ovarian Cancer
  • +2 more
  • PEip (weekly) and TCiv
  • TCiv
  • Nanjing, Jiangsu, China
  • +6 more
Dec 15, 2016

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Pittsburgh (RAD001, bevacizumab)

Completed
  • Ovarian Cancer
  • +2 more
  • Pittsburgh, Pennsylvania
    Magee-Womens Hospital of UPMC
Jul 19, 2016

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Shanghai (Total or Subtotal Colectomy,

Unknown status
  • Epithelial Ovarian Cancer
  • +3 more
  • Total or Subtotal Colectomy
  • Other Bowel Resection
  • Shanghai, Shanghai, China
    Fudan University Shanghai Zhongshan Hospital
Jul 23, 2016

Ovarian Carcinoma, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma Trial in Brussels, Liège (HIPEC)

Completed
  • Ovarian Carcinoma
  • +2 more
  • HIPEC
  • Brussels, Belgium
  • +1 more
Feb 23, 2016

Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma Trial in United States (3-Dimensional

Completed
  • Fallopian Tube Carcinoma
  • +4 more
  • 3-Dimensional Conformal Radiation Therapy
  • +2 more
  • Chicago, Illinois
  • +6 more
Feb 10, 2016

Ovarian Adenocarcinoma, Fallopian Tube Adenocarcinoma, Primary Peritoneal Carcinoma Trial in Villejuif (Cisplatin, Bevacizumab)

Completed
  • Ovarian Adenocarcinoma
  • +2 more
  • Villejuif, Val de Marne, France
    Gustave Roussy
Jan 25, 2016

Women at Elevated Genetic Risk for Ovarian Cancer Who

Not yet recruiting
  • Fallopian Tube Carcinoma
  • +3 more
  • Evaluation of Cancer Risk Factors
  • +2 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
May 27, 2015

Primary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma, Stage IV Ovarian Cancer Trial in Duarte (biological, drug, other)

Completed
  • Primary Peritoneal Carcinoma
  • +2 more
  • Bevacizumab
  • +2 more
  • Duarte, California
    City of Hope Comprehensive Cancer Center
May 8, 2015

Fallopian Tube Carcinoma, Malignant Ovarian Mixed Epithelial Tumor, Ovarian Brenner Tumor Trial in Philadelphia (Carboplatin,

Completed
  • Fallopian Tube Carcinoma
  • +10 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
May 7, 2015

Epithelial Ovarian Carcinoma, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma Trial in Seongnam-si (weekly paclitaxel,

Unknown status
  • Epithelial Ovarian Carcinoma
  • +2 more
  • weekly paclitaxel
  • +2 more
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
    Seoul National University Bundang Hospital
Jan 22, 2015

Fallopian Tube Carcinoma, Infectious Disorder, Neutropenia Trial in United States (procedure, drug, biological)

Completed
  • Fallopian Tube Carcinoma
  • +6 more
  • Adjuvant Therapy
  • +3 more
  • Orange, California
  • +10 more
Dec 29, 2014

Ovarian Carcinoma, Primary Peritoneal Carcinoma Trial in St. Louis (Pemetrexed, Bevacizumab)

Completed
  • Ovarian Carcinoma
  • Primary Peritoneal Carcinoma
  • St. Louis, Missouri
    Washington University School of Medicine
Oct 10, 2014